You are here

  • Home
  • Archive
  • Volume 11, Issue 8
  • Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trial

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trial

 

Online download statistics by month:

Online download statistics by month: August 2023 to January 2026

AbstractFullPdf
Aug 2023879888208
Sep 202327227253
Oct 202322622655
Nov 202316316353
Dec 202316816969
Jan 202417317360
Feb 202413913938
Mar 202415815966
Apr 202414614664
May 202414114252
Jun 202415015044
Jul 202414114252
Aug 2024626141
Sep 2024828248
Oct 2024535948
Nov 2024565743
Dec 2024737452
Jan 2025656539
Feb 2025485246
Mar 2025797948
Apr 2025979737
May 202511611652
Jun 2025515140
Jul 2025110
Jan 2026220
Total354135651308